Clinical Trial Update: Study in Major Depressive Disorder With NMRA-335140 (BTRX-335140) vs Placebo [Phase 2]

View source ↗

Summary

Phase 2 trial in major depressive disorder comparing NMRA-335140 (BTRX-335140) to placebo has completed and results have been posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• BTRX-335140 (NMRA-335140)

Snippet

Sponsor: Neumora Therapeutics, Inc. | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED | Results posted: 2025-05-29